MoonLake Immunotherapeutics Proceeds from Short-term Debt
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2023-05-11
- MoonLake Immunotherapeutics proceeds from short-term debt for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- MoonLake Immunotherapeutics proceeds from short-term debt for the quarter ending 2022-03-31 was $15.00M.
- MoonLake Immunotherapeutics proceeds from short-term debt for fiscal 2022 was $0.00.
| Period end | Proceeds from Short-term Debt 3 month | Proceeds from Short-term Debt 10 month | Proceeds from Short-term Debt 12 month |
|---|---|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | $0.00 10-K · filed 2023-03-20 | ||
| 2022-03-31 | $15.00M 10-Q · filed 2023-05-11 | ||
| 2021-12-31 | $15.00M 10-K · filed 2023-03-20 |